Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 516895, 6 pages
http://dx.doi.org/10.1155/2015/516895
Research Article

The Association of Serum IL-33 and sST2 with Breast Cancer

Oncology Department, The First Affiliated Hospital of Jiaxing University, Jiaxing 314001, China

Received 30 April 2015; Revised 27 August 2015; Accepted 27 August 2015

Academic Editor: Olav Lapaire

Copyright © 2015 Zhi-Ping Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Rugül Köse Çınar, Yasemin Görgülü, Okan Çalıyurt, and Bülent Sönmez, “Transient changes in inflammatory and oxidative stress markers with total sleep deprivation,” Sleep and Biological Rhythms, 2016. View at Publisher · View at Google Scholar
  • Michael M. Kunze, Fabienne Benz, Thilo F. Brauß, Sebastian Lampe, Julia E. Weigand, Johannes Braun, Florian M. Richter, Ilka Wittig, Bernhard Brüne, and Tobias Schmid, “sST2 translation is regulated by FGF2 via an hnRNP A1-mediated IRES-dependent mechanism,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2016. View at Publisher · View at Google Scholar
  • Frank Lezoualc'h, Loubina Fazal, Marion Laudette, and Caroline Conte, “Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease,” Circulation Research, vol. 118, no. 5, pp. 881–897, 2016. View at Publisher · View at Google Scholar
  • Javier Mora, and Andreas Weigert, “IL-1 family cytokines in cancer immunity - A matter of life and death,” Biological Chemistry, vol. 397, no. 11, pp. 1125–1134, 2016. View at Publisher · View at Google Scholar
  • Haiyan Hu, Jiaxing Sun, Chunhong Wang, Xiangmao Bu, Xiangping Liu, Yan Mao, and Haibo Wang, “IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties,” Biochemical and Biophysical Research Communications, vol. 485, no. 3, pp. 643–650, 2017. View at Publisher · View at Google Scholar
  • Valeria Lucarini, Giovanna Ziccheddu, Iole Macchia, Valentina La Sorsa, Francesca Peschiaroli, Carla Buccione, Antonella Sistigu, Massimo Sanchez, Sara Andreone, Maria Teresa D'Urso, Massimo Spada, Daniele Macchia, Claudia Afferni, Fabrizio Mattei, and Giovanna Schiavoni, “IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils,” OncoImmunology, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Yujiang Fang, Lei Zhao, Huaping Xiao, Kathryn M. Cook, Qian Bai, Elizabeth J. Herrick, Xuhui Chen, Chenglu Qin, Ziwen Zhu, Mark R. Wakefield, and Michael B. Nicholl, “IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer,” Medical Oncology, vol. 34, no. 2, 2017. View at Publisher · View at Google Scholar
  • Marie-Hélène Wasmer, and Philippe Krebs, “The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment,” Frontiers in Immunology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Kristen Larsen, Maydelis Minaya, Vivek Vaish, and Maria Peña, “The Role of IL-33/ST2 Pathway in Tumorigenesis,” International Journal of Molecular Sciences, vol. 19, no. 9, pp. 2676, 2018. View at Publisher · View at Google Scholar
  • Jaewoo Hong, Soohyun Kim, and P. Charles Lin, “Interleukin-33 and ST2 Signaling in Tumor Microenvironment,” Journal of Interferon & Cytokine Research, 2018. View at Publisher · View at Google Scholar
  • Azadeh Andishe-Tadbir, “Investigation of IL-33 serum levels in patients with benign and malignant salivary gland tumors,” Cancer Biomarkers, pp. 1–5, 2018. View at Publisher · View at Google Scholar
  • Jun-Li Wang, Jia Liu, Ke-Gong Xie, Chang-Gong Lan, Lu Lu, and Yu-Jin Tang, “ Association between functional polymorphisms in IL-33 / ST2 pathway and risk of osteosarcoma ,” Journal of Cellular and Molecular Medicine, 2018. View at Publisher · View at Google Scholar
  • Sowa Pawel, Misiolek Maciej, Zielinski Maciej, Mazur Bogdan, and Adamczyk-Sowa Monika, “Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors,” Experimental Biology and Medicine, vol. 243, no. 9, pp. 762–769, 2018. View at Publisher · View at Google Scholar
  • Dev Karan, “Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Jia-Xin Shen, Jing Liu, and Guo-Jun Zhang, “Interleukin-33 in Malignancies: Friends or Foes?,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Markus Kieler, Matthias Unseld, Johann Wojta, Alexandra Kaider, Daniela Bianconi, Svitlana Demyanets, and Gerald W. Prager, “Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy,” Medical Oncology, vol. 36, no. 1, 2018. View at Publisher · View at Google Scholar
  • Kevin J. Baker, Aileen Houston, and Elizabeth Brint, “IL-1 Family Members in Cancer; Two Sides to Every Story,” Frontiers in Immunology, vol. 10, 2019. View at Publisher · View at Google Scholar